What are the challenges in studying diseases treated with ERT?
Studying diseases treated with ERT poses several challenges, including the rarity of these conditions, which can make it difficult to gather sufficient data for robust statistical analysis. Additionally, heterogeneity in disease presentation and progression, variations in treatment response, and differences in healthcare access can complicate epidemiological studies. Longitudinal studies and international collaborations are often necessary to overcome these challenges.
